Yasuo Katayama

8.1k total citations · 1 hit paper
212 papers, 6.4k citations indexed

About

Yasuo Katayama is a scholar working on Neurology, Neurology and Epidemiology. According to data from OpenAlex, Yasuo Katayama has authored 212 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Neurology, 44 papers in Neurology and 38 papers in Epidemiology. Recurrent topics in Yasuo Katayama's work include Acute Ischemic Stroke Management (31 papers), Neuroscience and Neuropharmacology Research (22 papers) and Neuroinflammation and Neurodegeneration Mechanisms (22 papers). Yasuo Katayama is often cited by papers focused on Acute Ischemic Stroke Management (31 papers), Neuroscience and Neuropharmacology Research (22 papers) and Neuroinflammation and Neurodegeneration Mechanisms (22 papers). Yasuo Katayama collaborates with scholars based in Japan, United States and France. Yasuo Katayama's co-authors include Ken‐ichiro Katsura, Sadamitsu Asoh, Shigeo Ohta, Ikuroh Ohsawa, Kumi Yamagata, Kumiko Takahashi, Megumi Watanabe, Kiyomi Nishimaki, Masahiro Ishikawa and Masayuki Ueda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Immunology.

In The Last Decade

Yasuo Katayama

203 papers receiving 6.3k citations

Hit Papers

Hydrogen acts as a therapeutic antioxidant by selectively... 2007 2026 2013 2019 2007 500 1000 1.5k 2.0k

Peers

Yasuo Katayama
Ronald J. Korthuis United States
Jeffrey R. Kirsch United States
L. Creed Pettigrew United States
Tobias Eckle United States
Ethan A. Winkler United States
John W. Calvert United States
Yasuo Katayama
Citations per year, relative to Yasuo Katayama Yasuo Katayama (= 1×) peers Ken‐ichiro Katsura

Countries citing papers authored by Yasuo Katayama

Since Specialization
Citations

This map shows the geographic impact of Yasuo Katayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Katayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Katayama more than expected).

Fields of papers citing papers by Yasuo Katayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Katayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Katayama. The network helps show where Yasuo Katayama may publish in the future.

Co-authorship network of co-authors of Yasuo Katayama

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Katayama. A scholar is included among the top collaborators of Yasuo Katayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Katayama. Yasuo Katayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uchiyama, Shinichiro, Yukito Shinohara, Yasuo Katayama, et al.. (2014). Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2. Cerebrovascular Diseases. 37(4). 296–303. 39 indexed citations
2.
Katsumata, Toshiya, Tatsuo Otori, Seiji Okubo, et al.. (2010). Correlation between insulin resistance and white matter lesions among non-diabetic patients with ischemic stroke. Neurological Research. 32(7). 743–747. 22 indexed citations
3.
Yamashita, Toru, Tatsushi Kamiya, Kentaro Deguchi, et al.. (2010). Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 122(3). 195–197. 25 indexed citations
5.
Nishiyama, Yasuhiro, et al.. (2010). Early Depressive Symptoms after Ischemic Stroke Are Associated with a Left Lenticulocapsular Area Lesion. Journal of Stroke and Cerebrovascular Diseases. 19(3). 184–189. 34 indexed citations
6.
Kamiya, Nobuo, Masayuki Ueda, Hironaka Igarashi, et al.. (2008). Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sciences. 83(11-12). 433–437. 90 indexed citations
7.
Katsumata, Toshiya & Yasuo Katayama. (2006). [Treatment by medicine which improves cerebral circulation and metabolism].. PubMed. 64 Suppl 8. 81–4. 3 indexed citations
8.
Utsumi, Kouichi, Yuko Kamada, Yuichi Komaba, et al.. (2006). Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis. Clinica Chimica Acta. 377(1-2). 198–200. 30 indexed citations
9.
Takei, Hiroyuki, Yuichi Komaba, Hiroshi Kitamura, et al.. (2004). Aneurysmal subarachnoid hemorrhage in a patient with Wegener?s granulomatosis. Clinical and Experimental Nephrology. 8(3). 274–278. 21 indexed citations
10.
Mishina, Masahiro, Michio Senda, Motohiro Kiyosawa, et al.. (2003). Increased regional cerebral blood flow but normal distribution of GABAA receptor in the visual cortex of subjects with early-onset blindness. NeuroImage. 19(1). 125–131. 10 indexed citations
11.
Otori, Tatsuo, Toshiya Katsumata, Hiromi Muramatsu, et al.. (2003). Long‐term measurement of cerebral blood flow and metabolism in a rat chronic hypoperfusion model. Clinical and Experimental Pharmacology and Physiology. 30(4). 266–272. 133 indexed citations
12.
Nishiyama, Yasuhiro, Hiromasa Hamada, Satoshi Nonaka, et al.. (2002). Homeostatic Regulation of Intestinal Villous Epithelia by B Lymphocytes. The Journal of Immunology. 168(6). 2626–2633. 20 indexed citations
14.
Katsumata, Toshiya, et al.. (1999). Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. European Journal of Pharmacology. 372(2). 167–174. 27 indexed citations
15.
Yamazaki, Mineo, Kiyomitsu Oyanagi, Osamu Mori, et al.. (1999). Variant Gerstmann-Sträussler syndrome with the P105L prion gene mutation: an unusual case with nigral degeneration and widespread neurofibrillary tangles. Acta Neuropathologica. 98(5). 506–511. 33 indexed citations
16.
Katayama, Yasuo, Hiromi Muramatsu, Tatsushi Kamiya, Ann C. McKee, & Akiro Terashi. (1997). Ischemic tolerance phenomenon from an approach of energy metabolism and the mitochondrial enzyme activity of pyruvate dehydrogenase in gerbils. Brain Research. 746(1-2). 126–132. 18 indexed citations
17.
Otsubo, Kazumasa, et al.. (1993). Protective effects of glycerol and mannitol on delayed neuronal death in the gerbil hippocampus.. Journal of Nippon Medical School. 60(4). 231–240. 5 indexed citations
18.
Kashiwagi, Fumihiko, Yasuo Katayama, Tatsushi Kamiya, & Akiro Terashi. (1992). The effect of treatment with different timings of glycerol on experimental brain ischemia.. Nosotchu. 14(6). 583–590.
19.
Kashiwagi, Fumihiko, Yasuo Katayama, Hajime Memezawa, & Akiro Terashi. (1992). Effect of glycerol administration on experimental brain ischemia. Part 2. Studies on variable dose effectiveness.. Nosotchu. 14(2). 179–186.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026